Is there an association between #ultraprocessedfood intake & #colorectal #cancer incidence?🍔

Leila Abar &co answer this Q in a prospective cohort study, finding no overall association & suggesting that nutritional composition may be more relevant than food processing levels🧪 #MedSky
plos.io/4ysUKIq

🟡 Not standard: Aspirin isn’t standard cancer care, rare colorectal use.
🔴 Trial: No benefit after liver metastasis, more bleeding.
⚠️ Advice: Oncologist guidance needed.
#AspirinCancer #Colorectal #AspirinBleeding #OncologyAdvice
View in Timelines

#cancer #Colorectal cancer #disease
🌐 www.newsmart.ch

New in Comprehensive Physiology 🚨 Integrated Multi-Omics Analysis Identifies #HVCN1 as a 0Potential Mediator in #Neuroendocrine–Tumor Interactions in #Colorectal Cancer. Read: https://ow.ly/WXQY50ZRxl4 #CRC

#dostarlimab #jemperli #atezolizumab #tecentriq #patientvoice #HTA #chemotherapy #patientinput #patient #survivor #caregiver #survey #HTAsubmission #colorectalcancer #cancer #colorectal #colon #rectal #treatment #therapy #realworldevidence #patientexperience

Save the date! 🇧🇪

We’re excited to welcome you to Mechelen on 21–22 January 2027 for the 18th ESCP Masterclass on Pelvic Floor Pathology, in collaboration with BSCRS.
Register at www.rbss.be/bscrs

#colorectal #escp #bscrs

🦠🔬 #Infection with the common #stomach #bacterium #Helicobacter Pylori may be associated with an increased risk of #colorectal #cancer, adding to evidence of its effects beyond the stomach.

#Microbes #Bacteria #GutHealth #Microsky via @theconversation.com

theconversation.com/a-common-sto...

#border #cancer #Colorectal cancer #continent #disease #evidence #population #scientist #scientists #Vienna
🌐 www.newsmart.ch

#Bacteroides acidifaciens enriched by KRAS mutation promotes #colorectal tumorigenesis.

KRAS‑mutant #colorectalcancer selects B. acidifaciens, whose SusF stabilizes ARHGEF2 to amplify KRAS–ERK signaling and drive tumorigenesis.

www.sciencedirect.com/science/arti... #cancer #microbiology #MicroSky

On #TAMO in 2025.
.
In a retrospective 20-center study, a depth of response ≥15% independently predicted longer PFS in pre-treated BRAFV600E #mCRC receiving encorafenib + cetuximab ± binimetinib.
Read more:
journals.sagepub.com/doi/full/10....
@Guv_onc @ChiaraCrem1 #colorectal #cancer